Brian Zambrowicz
-
- Diabetes Treatment and Management 18
- Pituitary Gland Disorders and Treatments 8
- Nephrology top 2%
- Molecular Biology top 2%
- CRISPR and Genetic Engineering 11
- Metabolism, Diabetes, and Cancer 8
- Nutrition and Dietetics top 1%
- Genetics top 2%
- Animal Genetics and Reproduction 7
-
- Pancreatic function and diabetes 16
-
- Neuroendocrine Tumor Research Advances 11
-
- Neuroblastoma Research and Treatments 7
- Co-authors
- Arthur SandsPhilippe SorianoLeonard A. HerzenbergSteve FieringWilliam G. KerrAkira ImamotoRichard D. PalmiterGlenn A. Friedrich
- Journals
- Nature (1 paper)Proceedings of the National Academy of Sciences (4 papers)Journal of Biological Chemistry (1 paper)
- Partner nations
- United StatesGermanyCzechia
In The Last Decade
Brian Zambrowicz
80 papers receiving 6.6k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Endocrinology, Diabetes and Metabolism 1.7k
- Nephrology 360
- Molecular Biology 3.4k
- Nutrition and Dietetics 599
- Genetics 1.1k
Countries citing papers authored by Brian Zambrowicz
This map shows the geographic impact of Brian Zambrowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Zambrowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Zambrowicz more than expected).
Fields of papers citing papers by Brian Zambrowicz
This network shows the impact of papers produced by Brian Zambrowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Zambrowicz. The network helps show where Brian Zambrowicz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Brian Zambrowicz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2022 | 18 | |
| 3 | 2022 | 1 | |
| 4 | 2021 | 9 | |
| 5 | 2020 | 79 | |
| 6 | 2018 | 40 | |
| 7 | Telotristat etiprate shows benefit in treating patients With carcinoid syndrome that is inadequately controlled by somatostatin analog therapy in the phase 3 TELESTAR clinical trial | 2016 | 1 |
| 8 | 2014 | 44 | |
| 9 | 2014 | 34 | |
| 10 | 2013 | 12 | |
| 11 | 2013 | 156 | |
| 12 | 2013 | 65 | |
| 13 | 2012 | 202 | |
| 14 | 2009 | 105 | |
| 15 | 2007 | 155 | |
| 16 | 2007 | 41 | |
| 17 | 2007 | 31 | |
| 18 | 2002 | 32 | |
| 19 | 2001 | 241 | |
| 20 | 1998 | 36 |
About Brian Zambrowicz
Brian Zambrowicz is a scholar working on Endocrinology, Diabetes and Metabolism, Gastroenterology and Molecular Biology, having authored 82 papers that have together received 6.8k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (18 papers), Pancreatic function and diabetes (16 papers), CRISPR and Genetic Engineering (11 papers), Neuroendocrine Tumor Research Advances (11 papers), Pituitary Gland Disorders and Treatments (8 papers), Metabolism, Diabetes, and Cancer (8 papers), Neuroblastoma Research and Treatments (7 papers) and Animal Genetics and Reproduction (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.7k citations), Nephrology (360 citations) and Molecular Biology (3.4k citations). Brian Zambrowicz has collaborated with scholars based in United States, Germany and Czechia. Frequent co-authors include Arthur Sands, Philippe Soriano, Leonard A. Herzenberg, Steve Fiering, William G. Kerr, Akira Imamoto, Richard D. Palmiter, Glenn A. Friedrich, Pablo Lapuerta and Gwenn M. Hansen. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.